Showing results (161-170 of 437) with videos related to

Sort By:
Pageof 44
Molecular Cancer Therapeutics|July 3, 2007
The alkylphospholipid perifosine induces apoptosis of human lung cancer cells requiring inhibition of Akt and activation of the extrinsic apoptotic pathwayHeath A Elrod, Yi-Dan Lin, Ping Yue, et al.
Cancer|April 7, 2006
Maintenance therapy with thalidomide improves overall survival after autologous hematopoietic progenitor cell transplantation for multiple myelomaBrett T Brinker, Edmund K Waller, Traci Leong, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 28, 2026
High-Risk Multiple Myeloma: Redefining Risk and Rethinking TherapyGareth J Morgan, Dennis D Lee, Nisha S Joseph, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 19, 2003
Pharmacokinetics and pharmacodynamics of anti-thymocyte globulin in recipients of partially HLA-matched blood hematopoietic progenitor cell transplantationEdmund K Waller, Amelia A Langston, Sagar Lonial, et al.
Cancer|October 11, 2018
Response to therapeutic monoclonal antibodies for multiple myeloma in African Americans versus whitesSarah Chehab, Chao Zhang, Elyse H Panjic, et al.
Nucleic Acids Research|December 2, 2016
MAX is an epigenetic sensor of 5-carboxylcytosine and is altered in multiple myelomaDongxue Wang, Hideharu Hashimoto, Xing Zhang, et al.
Cancer Research|November 19, 2009
Perifosine inhibits mammalian target of rapamycin signaling through facilitating degradation of major components in the mTOR axis and induces autophagyLei Fu, Young-Ae Kim, Xuerong Wang, et al.
Blood Cancer Journal|September 8, 2018
Lenalidomide and dexamethasone in patients with relapsed multiple myeloma and impaired renal function: PrE1003, a PrECOG studyJoseph Mikhael, Judith Manola, Amylou C Dueck, et al.
Cancer|January 22, 2005
Thalidomide in the treatment of patients with hepatocellular carcinoma: a phase II trialYehuda Z Patt, Manal M Hassan, Richard D Lozano, et al.
Cancer|November 8, 2014
Predictors of survival outcomes in phase 1 relapsed or refractory multiple myeloma patientsMeagan S Barbee, Ajay Nooka, Jonathan L Kaufman, et al.
Pageof 44